---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-065322"
form_type: "8-K"
ticker: "APGE"
cik: "0001974640"
company_name: "Apogee Therapeutics, Inc."
filed_at: "2024-05-28T23:59:59+00:00"
generated_at: "2026-06-01T08:23:31.325090+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Apogee Therapeutics appoints Lisa Bollinger, MD to board of directors

## Summary
- Lisa Bollinger, MD elected as Class II director, effective May 28, 2024.
- Bollinger brings 30+ years in drug development; most recently VP Regulatory Affairs at Merck (MRK).
- She also served as VP Global Patient Safety at Amgen and 12 years at FDA.
- Will serve on the Nominating and Corporate Governance Committee.
- Appointment adds regulatory and safety expertise as Apogee advances two clinical programs.

## SEC filing metadata
- accession: 0001104659-24-065322
- form_type: 8-K
- ticker: APGE
- cik: 0001974640
- company_name: Apogee Therapeutics, Inc.
- filed_at: 2024-05-28T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1974640/000110465924065322/0001104659-24-065322-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1974640/000110465924065322/tm2415611d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-065322
- JSON: https://secwatch.observer/filing/0001104659-24-065322.json
- Plain text: https://secwatch.observer/filing/0001104659-24-065322.txt

## Key facts
- Executive change
  Lisa L. Bollinger was elected as Class II director at Apogee Therapeutics, Inc..
  - Action: elected
  - Role: Class II director
  source text: the board of directors (the “Board”) of Apogee Therapeutics, Inc. (the “Company”) elected Lisa L. Bollinger, M.D. to serve as a Class II director of the Company
  evidence_url: https://www.sec.gov/Archives/edgar/data/1974640/000110465924065322/0001104659-24-065322-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.